sec filing
CL
NASDAQ · CLYM
Climb Bio, Inc.
Healthcare · Biotechnology
$15.52
Up+$0.93 (+6.37%)
Updated Sep 7, 2026, 11:39 PM
SID Score
5.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 157.17M
- P/E ratio
- -3.33
- Dividend yield
- 0.00%
- 52-week range
- $5.87 – $18.33
- Volume
- 1.5M
- Avg. volume
- 598.77K
Price performance
CLYM price history
1M range · 20 trading sessions · Daily adjusted prices
CLYM closed at $15.52 after 20 trading sessions, up 14.62% for the selected period.
- Last close
- $15.52
- Period change
- +14.62%
- Period low
- $13.54
- Period high
- $17.84
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 4, 2026 | $14.49 | $15.96 | $14.28 | $15.52 | 1.5M |
| Sep 3, 2026 | $13.96 | $15.39 | $13.60 | $14.59 | 5.53M |
| Sep 2, 2026 | $14.79 | $15.29 | $14.40 | $15.05 | 2.21M |
| Sep 1, 2026 | $13.88 | $15.03 | $13.09 | $14.82 | 1.97M |
| Aug 31, 2026 | $14.58 | $14.695 | $13.4901 | $13.73 | 1.44M |
| Aug 28, 2026 | $14.86 | $15.13 | $14.37 | $14.57 | 840.93K |
| Aug 27, 2026 | $16.09 | $16.33 | $14.935 | $15.06 | 1.56M |
| Aug 26, 2026 | $17.72 | $17.80 | $16.01 | $16.08 | 1.39M |
| Aug 25, 2026 | $16.75 | $18.33 | $16.75 | $17.84 | 1.2M |
| Aug 24, 2026 | $17.27 | $17.41 | $16.05 | $16.40 | 1.18M |
| Aug 21, 2026 | $17.26 | $17.71 | $17.00 | $17.28 | 957.41K |
| Aug 20, 2026 | $17.16 | $17.45 | $16.72 | $17.02 | 903.93K |
| Aug 19, 2026 | $18.09 | $18.135 | $16.58 | $17.34 | 1.29M |
| Aug 18, 2026 | $16.90 | $17.53 | $16.45 | $17.39 | 1.16M |
| Aug 17, 2026 | $16.25 | $17.52 | $15.84 | $17.44 | 1.87M |
| Aug 14, 2026 | $15.06 | $17.00 | $14.24 | $16.33 | 2.5M |
| Aug 13, 2026 | $14.58 | $15.21 | $14.505 | $14.73 | 1.58M |
| Aug 12, 2026 | $13.97 | $14.55 | $13.61 | $14.39 | 1.32M |
| Aug 11, 2026 | $13.67 | $13.98 | $13.23 | $13.85 | 707.2K |
| Aug 10, 2026 | $13.80 | $13.86 | $13.20 | $13.54 | 779.55K |
Latest CLYM news
The latest Smart Investors Daily articles mentioning CLYM.
Stock researchCompany · Overview
Loading stock research…